subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Treatment related acute myeloid leukaemia

tested_intervention: unsure


subject: CHEBI:93775

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:93775

object_name: Malignant myeloproliferative neoplasm


subject: CHEBI:93775

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:93775

object_name: chronic myelomonocytic leukemia


subject: CHEBI:93775

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:93775

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:93775

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:93775

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:93775

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:93775

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: triple-negative breast carcinoma

tested_intervention: yes


subject: UMLS:C4086499

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:177605

subject_name: Samidorphan

object_name: alcohol abuse


subject: CHEBI:177605

object_name: alcohol dependence


subject: UNII:2R27AB6766

subject_name: Caplacizumab

object_name: thrombotic thrombocytopenic purpura


subject: UNII:2R27AB6766

object_name: Thrombotic Thrombocytopenic Purpura, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:73505

subject_name: Glu-Gly


subject: CHEBI:73505


subject: CHEBI:25902

subject_name: pentyl group


subject: CHEBI:25902


subject: CHEBI:17553


subject: CHEBI:17553


subject: CHEBI:74762

subject_name: Pro-Glu


subject: CHEBI:74762


subject: CHEBI:16038

subject_name: phosphatidylethanolamine


subject: CHEBI:16038


subject: PR:000013200

subject_name: prolyl endopeptidase


subject: PR:000013200


subject: CHEBI:4445

subject_name: Desflurane

object_name: kidney failure


subject: CHEBI:4445

object_name: Renal Failure, CTCAE


subject: UMLS:C4287786

object_name: non-small cell lung carcinoma


subject: UNII:06DX01190R

subject_name: Ridinilazole

object_name: Clostridium difficile colitis


subject: UNII:06DX01190R

object_name: clostridium difficile infection


subject: UMLS:C1360419

subject_name: Herbal Drugs

object_name: periodontal disorder


subject: CHEBI:53074

subject_name: Diphencyprone

object_name: melanoma


subject: CHEBI:53074

object_name: Neoplasm Metastasis


subject: CHEBI:52717

subject_name: Bortezomib

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:52717

object_name: intraocular lymphoma


subject: CHEBI:52717

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:52717

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:52717

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:52717

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Marginal zone lymphoma stage I


subject: CHEBI:52717

object_name: Stage I Adult Burkitt Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:52717

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:52717

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:52717

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: CHEBI:52717

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:52717

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:52717

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:52717

object_name: refractory hairy cell leukemia


subject: CHEBI:52717

object_name: Untreated Hairy Cell Leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: primary cutaneous B-cell lymphoma


subject: UNII:PVI5M0M1GW

object_name: intraocular lymphoma


subject: UNII:PVI5M0M1GW

object_name: small intestine lymphoma


subject: UNII:PVI5M0M1GW

object_name: B-cell small lymphocytic lymphoma stage I


subject: UNII:PVI5M0M1GW

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:PVI5M0M1GW

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:PVI5M0M1GW

object_name: B-cell small lymphocytic lymphoma stage III


subject: UNII:PVI5M0M1GW

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Marginal zone lymphoma stage I


subject: UNII:PVI5M0M1GW

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage I Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: MALT lymphoma


subject: UNII:PVI5M0M1GW

object_name: splenic marginal zone lymphoma


subject: UNII:PVI5M0M1GW

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:PVI5M0M1GW

object_name: Marginal zone lymphoma stage IV


subject: UNII:PVI5M0M1GW

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage III Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Marginal zone lymphoma stage III


subject: UNII:PVI5M0M1GW

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UNII:PVI5M0M1GW

object_name: refractory hairy cell leukemia


subject: UNII:PVI5M0M1GW

object_name: Untreated Hairy Cell Leukemia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: primary cutaneous B-cell lymphoma


subject: PR:000005932

object_name: intraocular lymphoma


subject: PR:000005932

object_name: small intestine lymphoma


subject: PR:000005932

object_name: B-cell small lymphocytic lymphoma stage I


subject: PR:000005932

object_name: Stage I Adult Lymphoblastic Lymphoma


subject: PR:000005932

object_name: B-cell small lymphocytic lymphoma stage IV


subject: PR:000005932

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: PR:000005932

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PR:000005932

object_name: B-cell small lymphocytic lymphoma stage III


subject: PR:000005932

object_name: Stage III Adult Lymphoblastic Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PR:000005932

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: PR:000005932

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: PR:000005932

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: PR:000005932

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PR:000005932

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PR:000005932

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: PR:000005932

object_name: Stage I Adult Immunoblastic Lymphoma


subject: PR:000005932

object_name: nodal marginal zone B-cell lymphoma


subject: PR:000005932

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Contiguous Adult Lymphoblastic Lymphoma


subject: PR:000005932

object_name: Marginal zone lymphoma stage I


subject: PR:000005932

object_name: Stage III Adult Immunoblastic Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: PR:000005932

object_name: Stage I Adult Burkitt Lymphoma


subject: PR:000005932

object_name: MALT lymphoma


subject: PR:000005932

object_name: splenic marginal zone lymphoma


subject: PR:000005932

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: PR:000005932

object_name: Marginal zone lymphoma stage IV


subject: PR:000005932

object_name: Stage IV Adult Burkitt Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Non-Contiguous Adult Lymphoblastic Lymphoma


subject: PR:000005932

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000005932

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000005932

object_name: Stage III Adult Burkitt Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Burkitt Lymphoma


subject: PR:000005932

object_name: Marginal zone lymphoma stage III


subject: PR:000005932

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: PR:000005932

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: PR:000005932

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: PR:000005932

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: PR:000005932

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage I Grade 3 Follicular Lymphoma


subject: PR:000005932

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Grade III Lymphomatoid Granulomatosis


subject: PR:000005932

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: PR:000005932

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: PR:000005932

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PR:000005932

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PR:000005932

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage III Grade 3 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Non-Contiguous Adult Burkitt Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma


subject: PR:000005932

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: PR:000005932

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: PR:000005932

object_name: refractory hairy cell leukemia


subject: PR:000005932

object_name: Untreated Hairy Cell Leukemia


subject: UMLS:C3827117

object_name: bladder tumor


subject: UMLS:C3827117

object_name: urinary bladder carcinoma


subject: UMLS:C3827117

object_name: urinary bladder cancer


subject: UMLS:C3827117

object_name: childhood bladder carcinoma


subject: CHEBI:76128

subject_name: Dexketoprofen

object_name: migraine


subject: CHEBI:76128

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:107736


subject: CHEBI:41423

subject_name: Celecoxib

object_name: malignant soft tissue neoplasm


subject: CHEBI:41423

object_name: sarcoma


subject: CHEBI:41423

object_name: Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone


subject: CHEBI:41423

object_name: childhood malignant fibrous histiocytoma of bone


subject: UMLS:C1948073

object_name: chronic hepatitis C virus infection


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Wound healed (finding)


subject: PUBCHEM.COMPOUND:14907381

object_name: glaucoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Glaucoma, CTCAE


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEBI:150712


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: DRUGBANK:DB18742

object_name: fragile X syndrome


subject: DRUGBANK:DB17952

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: DRUGBANK:DB17952

object_name: amyotrophic lateral sclerosis


subject: CHEBI:50838

subject_name: Drospirenone

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:50838

object_name: Dysmenorrhea


subject: PR:000012938

subject_name: pinin


subject: PR:000012938


subject: UMLS:C1696294

subject_name: Yaz


subject: UMLS:C1696294


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: skin pigmentation disorder


subject: UNII:DEW6X41BEK

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UNII:DEW6X41BEK

object_name: vitiligo


subject: UNII:DEW6X41BEK

object_name: dilution, pigmentary


subject: UNII:DEW6X41BEK

object_name: hypopigmentation of the skin


subject: UNII:DEW6X41BEK

object_name: Hypopigmentation, CTCAE


subject: UNII:DEW6X41BEK

object_name: Skin and Connective Tissue Diseases


subject: UNII:DEW6X41BEK

object_name: skin disorder


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: bowel dysfunction


subject: UMLS:C1321801

object_name: intestinal disorder


subject: UMLS:C0225326

subject_name: fiber


subject: UMLS:C0225326


subject: UMLS:C1550678

subject_name: Water Specimen


subject: UMLS:C1550678


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: UMLS:C4741402

subject_name: Methyl B-12

object_name: autism


subject: PUBCHEM.COMPOUND:544190

object_name: respiratory tract infectious disorder


subject: CHEBI:7798

subject_name: Oseltamivir


subject: UMLS:C1527224

subject_name: Iodine (131-I) ethiodized oil

object_name: liver carcinoma


subject: UMLS:C1527224

object_name: viral hepatitis


subject: CHEBI:114785

subject_name: Erlotinib

object_name: untreated metastatic squamous neck cancer with occult primary


subject: CHEBI:114785

object_name: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: Stage IV Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:114785

object_name: recurrent midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: stage IV midline lethal granuloma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: stage IV esthesioneuroblastoma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: recurrent inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: stage IV inverted papilloma of the paranasal sinus and nasal cavity


subject: CHEBI:114785

object_name: Stage IV Lip Basal Cell Carcinoma


subject: CHEBI:114785

object_name: Recurrent Lip Basal Cell Carcinoma


subject: CHEBI:114785

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:114785

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:114785

object_name: Adenoid cystic carcinoma of the oral cavity recurrent


subject: CHEBI:114785

object_name: Adenoid cystic carcinoma of the oral cavity stage IV


subject: CHEBI:114785

object_name: Mucoepidermoid carcinoma of the oral cavity recurrent


subject: CHEBI:114785

object_name: Stage IV Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7


subject: CHEBI:114785

object_name: Verrucous carcinoma of the oral cavity stage IV


subject: CHEBI:114785


subject: CHEBI:114785

object_name: Laryngeal verrucous carcinoma stage IV


subject: CHEBI:114785

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:114785

object_name: Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7


subject: CHEBI:114785

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: stage IV pancreatic cancer


subject: CHEBI:114785

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:114785

object_name: Salivary gland cancer stage IV


subject: CHEBI:114785

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:114785

object_name: Mesothelioma malignant recurrent


subject: CHEBI:114785

object_name: Cervix carcinoma recurrent


subject: CHEBI:114785

object_name: Cervical carcinoma stage IVB


subject: CHEBI:114785

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: Stage IVB Cervical Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IVA Cervical Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: Cervical carcinoma stage IVA


subject: CHEBI:114785

object_name: malignant mesothelioma


subject: CHEBI:114785

object_name: Adult Myxopapillary Ependymoma


subject: CHEBI:114785

object_name: adult anaplastic ependymoma


subject: CHEBI:114785

object_name: Adult Pilocytic Astrocytoma


subject: CHEBI:114785

object_name: Prostate cancer recurrent


subject: CHEBI:114785

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:114785

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage III Esophageal Cancer


subject: CHEBI:114785

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:114785

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:114785

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:114785

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:114785

object_name: stage IV esophageal cancer


subject: CHEBI:114785

object_name: Stage II Esophageal Cancer AJCC v7


subject: CHEBI:114785

object_name: Stage II Esophageal Cancer


subject: CHEBI:114785

object_name: Recurrent Rectal Cancer


subject: CHEBI:114785

object_name: Adult Diffuse Astrocytoma


subject: CHEBI:114785

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:114785

object_name: Rectal cancer stage IV


subject: CHEBI:114785

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:114785

object_name: Anal cancer recurrent


subject: CHEBI:114785

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IV Bladder Cancer AJCC v7


subject: CHEBI:114785

object_name: Bladder cancer stage IV


subject: CHEBI:114785

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:114785

object_name: adult brainstem glioma


subject: CHEBI:114785

object_name: Breast cancer recurrent


subject: CHEBI:114785

object_name: adult oligodendroglioma


subject: CHEBI:114785

object_name: Anal cancer stage IV


subject: CHEBI:114785

object_name: Stage IV Anal Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IV Anal Canal Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: adult embryonal tumor with multilayered rosettes, c19mc-altered


subject: CHEBI:114785

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:114785

object_name: Carcinoma breast stage IV


subject: CHEBI:114785

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:114785

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:114785

object_name: Colon cancer recurrent


subject: CHEBI:114785

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:114785

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:114785

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:114785

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:114785

object_name: Adult Subependymoma


subject: CHEBI:114785

object_name: Adult Mixed Glioma


subject: CHEBI:114785

object_name: male breast carcinoma


subject: CHEBI:79033

subject_name: florbetaben F18

object_name: primary progressive aphasia


subject: CHEBI:79033

object_name: Alzheimer disease type 1


subject: CHEBI:79033

object_name: Alzheimer disease


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: leukemia


subject: UMLS:C0085297

object_name: childhood leukemia


subject: UMLS:C0085297

object_name: plasma cell myeloma


subject: UMLS:C0086333

subject_name: Gammagard


subject: UMLS:C0086333


subject: UMLS:C0086333


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: PUBCHEM.COMPOUND:11255911

subject_name: Tesofensine

object_name: type 2 diabetes mellitus


subject: CHEBI:16664

subject_name: Albendazole

object_name: hookworm infectious disease


subject: CHEBI:16664

object_name: trichuriasis


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: Nonorganic psychosis


subject: CHEBI:10119

object_name: Psychosis, CTCAE


subject: CHEBI:10119

object_name: schizophreniform disorder


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Seizure Related to COVID-19


subject: CHEBI:60648

object_name: epilepsy


subject: CHEBI:60648

object_name: visual epilepsy


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: colorectal cancer


subject: UNII:3M6325NY1R

object_name: colorectal carcinoma


subject: UNII:3M6325NY1R

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Prediabetes


subject: CHEBI:167574

object_name: puerperal disorder


subject: GTOPDB:9517

subject_name: atacicept

object_name: Multiple sclerosis relapse


subject: CHEMBL.COMPOUND:CHEMBL1742986

subject_name: ATACICEPT


subject: UMLS:C2351058

subject_name: Atacicept


subject: CHEBI:90933

subject_name: Cariprazine

object_name: cocaine use disorder


subject: CHEBI:90933

object_name: opiate dependence


subject: UMLS:C1681886

object_name: rheumatoid arthritis


subject: CHEBI:139072


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:6801

subject_name: Metformin

object_name: oral cavity carcinoma


subject: CHEBI:6801

object_name: Proliferative verrucous oral leukoplakia


subject: CHEBI:6801

object_name: erythroplakia


subject: CHEBI:6801

object_name: leukoplakia


subject: PUBCHEM.COMPOUND:66586232

object_name: neonatal sepsis


subject: PUBCHEM.COMPOUND:66586232

object_name: Bacterial sepsis of newborn


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: CHEBI:3614


subject: UMLS:C0008586

subject_name: Chromogranins


subject: UMLS:C0008586


subject: UMLS:C3195386

subject_name: Anascorp

object_name: Scorpion sting


subject: UMLS:C3195386

object_name: Scorpion sting causing poisoning and toxic reactions


subject: CHEBI:2948

subject_name: Azathioprine

object_name: acute myeloid leukemia by FAB classification


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Vulvar Vestibulitis


subject: UNII:UC95NQ339C

object_name: vulvar disease


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: PUBCHEM.COMPOUND:122173793

subject_name: eritoran

object_name: Insulin Sensitivity


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: secondary hyperparathyroidism of renal origin


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:231683

subject_name: Anakinra

object_name: Metastatic non-small cell lung cancer


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UNII:420K487FSG

subject_name: Dupilumab


subject: UMLS:C3658854


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: UMLS:C3252350

object_name: metastatic colorectal cancer


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: SARS (Disease)


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C1831996

subject_name: DTA-H19 Plasmid

object_name: pancreatic neoplasm


subject: CHEBI:90620

subject_name: Vatalanib

object_name: Neoplasm Metastasis


subject: CHEBI:90620

object_name: carcinoma


subject: UMLS:C0912413

subject_name: PTK 787


subject: UMLS:C0912413


subject: CHEBI:9150

subject_name: Simvastatin

object_name: asthma


subject: UNII:3JL137394Y

object_name: Ocular hypertension


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Antibiotic-associated diarrhea


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C0885571

subject_name: Lemon balm

object_name: Stress


subject: UMLS:C0885571

object_name: Mood Alteration


subject: CHEBI:8382

subject_name: Prednisone

object_name: Hospital acquired pneumonia


subject: UMLS:C4688608

subject_name: C5 Inhibitor RA101495

object_name: Myasthenia Gravis, Generalized


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:D6OMY2L0WA

object_name: high grade B-cell lymphoma


subject: UNII:D6OMY2L0WA

object_name: Lymphoma, Large-Cell, Follicular


subject: UNII:D6OMY2L0WA

object_name: high-grade B-cell lymphoma double-hit/triple-hit


subject: UNII:D6OMY2L0WA

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:D6OMY2L0WA

object_name: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: UMLS:C5206892


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:63115

subject_name: Fingolimod

object_name: schizophrenia


subject: MESH:C000712251

object_name: Duchenne muscular dystrophy


subject: GTOPDB:13087

subject_name: divozilimab

object_name: neuromyelitis optica


subject: CHEMBL.COMPOUND:CHEMBL5314981

subject_name: DIVOZILIMAB


subject: UMLS:C5446731

subject_name: Divozilimab


subject: UNII:T60AV22R32

subject_name: Chlorazine

object_name: Painful blind eye


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:91400

subject_name: Afatinib

object_name: Stomach cancer


subject: CHEBI:91400

object_name: gastric cancer


subject: CHEBI:94366

subject_name: itraconazole

object_name: autosomal dominant polycystic kidney disease


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:47426

subject_name: Furosemide

object_name: pulmonary embolism


subject: UMLS:C0068536

subject_name: Neosporin


subject: CHEBI:8499

subject_name: Propranolol

object_name: colorectal neoplasm


subject: CHEBI:4909

subject_name: Etodolac


subject: CHEBI:3640

subject_name: Chlorothiazide

object_name: heart failure


subject: CHEBI:3640

object_name: Heart Failure, CTCAE


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: UNII:WBX54NZ436

object_name: beta thalassemia


subject: UNII:WBX54NZ436

object_name: beta-thalassemia HBB/LCRB


subject: UNII:WBX54NZ436

object_name: Iron Overload


subject: UNII:WBX54NZ436

object_name: iron poisoning


subject: UNII:WBX54NZ436

object_name: Iron Overload, CTCAE


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: paraganglioma


subject: UNII:MRL3739G66

object_name: adrenal gland pheochromocytoma


subject: UNII:MRL3739G66

object_name: pheochromocytoma


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L


subject: UNII:Y68179SY2L


subject: UMLS:C5855518

subject_name: Lead Pb 203 VMT-a-NET


subject: UMLS:C5855518


subject: UMLS:C5855518


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: CHEMBL.COMPOUND:CHEMBL4650435


subject: UMLS:C4764272

subject_name: Botensilimab


subject: UMLS:C4764272


subject: UMLS:C4764272


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: nephroblastoma


subject: CHEBI:4026

object_name: Wilms tumor


subject: CHEBI:4026

object_name: childhood kidney Wilms tumor


subject: CHEBI:4026

object_name: germ cell tumor


subject: CHEBI:4026

object_name: rhabdoid tumor


subject: CHEBI:4026

object_name: renal cell adenocarcinoma


subject: CHEBI:4026

object_name: renal cell carcinoma


subject: CHEBI:4026

object_name: clear cell sarcoma


subject: CHEBI:4026

object_name: Ewing sarcoma


subject: CHEBI:4026

object_name: hepatoblastoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150

object_name: soft tissue sarcoma


subject: CHEBI:9150

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:9150

object_name: clear cell renal carcinoma


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150


subject: CHEBI:9150

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:9150

object_name: rhabdomyosarcoma


subject: CHEBI:9150

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:9150

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:9150

object_name: retinoblastoma


subject: CHEBI:9150


subject: CHEBI:9150

object_name: Childhood Neuroblastoma


subject: CHEBI:9150

object_name: neuroblastoma


subject: CHEBI:9150

object_name: pediatric osteosarcoma


subject: CHEBI:9150

object_name: Osteosarcoma


subject: CHEBI:63632

subject_name: Topotecan

object_name: nephroblastoma


subject: CHEBI:63632

object_name: Wilms tumor


subject: CHEBI:63632

object_name: childhood kidney Wilms tumor


subject: CHEBI:63632

object_name: germ cell tumor


subject: CHEBI:63632

object_name: rhabdoid tumor


subject: CHEBI:63632

object_name: soft tissue sarcoma


subject: CHEBI:63632

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:63632

object_name: clear cell renal carcinoma


subject: CHEBI:63632

object_name: renal cell adenocarcinoma


subject: CHEBI:63632

object_name: renal cell carcinoma


subject: CHEBI:63632

object_name: clear cell sarcoma


subject: CHEBI:63632

object_name: Ewing sarcoma


subject: CHEBI:63632

object_name: rhabdomyosarcoma


subject: CHEBI:63632

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:63632

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:63632

object_name: hepatoblastoma


subject: CHEBI:63632

object_name: liver carcinoma


subject: CHEBI:63632

object_name: pediatric osteosarcoma


subject: CHEBI:63632

object_name: Osteosarcoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: nephroblastoma


subject: PR:000005932

object_name: Wilms tumor


subject: PR:000005932

object_name: childhood kidney Wilms tumor


subject: PR:000005932

object_name: rhabdoid tumor


subject: PR:000005932

object_name: soft tissue sarcoma


subject: PR:000005932

object_name: nonpapillary renal cell carcinoma


subject: PR:000005932

object_name: clear cell renal carcinoma


subject: PR:000005932

object_name: renal cell adenocarcinoma


subject: PR:000005932

object_name: renal cell carcinoma


subject: PR:000005932

object_name: clear cell sarcoma


subject: PR:000005932

object_name: retinoblastoma


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000008945

subject_name: insulin-like growth factor 2 mRNA-binding protein 3

object_name: carcinoma of esophagus


subject: PR:000008945

object_name: esophageal cancer


subject: PR:000008945

object_name: Childhood Esophageal Carcinoma


subject: PR:000008945

object_name: neoplasm of esophagus


subject: UMLS:C0149473

subject_name: Zoladex

object_name: Childhood Breast Carcinoma


subject: UMLS:C0149473

object_name: breast carcinoma


subject: UMLS:C0149473

object_name: breast cancer


subject: UMLS:C5206404

subject_name: mRNA-derived KRAS-targeted Vaccine V941

object_name: non-small cell lung carcinoma


subject: UMLS:C5206404

object_name: pancreatic neoplasm


subject: UMLS:C5206404

object_name: colorectal neoplasm


subject: UMLS:C5206404

object_name: neoplasm


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: neuromyelitis optica


subject: UMLS:C4086207


subject: PUBCHEM.COMPOUND:6435378

subject_name: iloprost

object_name: Chronic uremia


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)

object_name: liver failure


subject: CHEBI:75275

object_name: Bleeding gastric varices


subject: UMLS:C0591931

subject_name: Ovysmen

object_name: hepatitis C


subject: UMLS:C4548293

object_name: cystic fibrosis


subject: CHEBI:71013

subject_name: Perampanel

object_name: Seizure Related to COVID-19


subject: CHEBI:71013

object_name: visual epilepsy


subject: CHEBI:32139

object_name: Oral hygiene status


subject: CHEBI:28741

subject_name: Sodium fluoride


subject: UMLS:C1171560

subject_name: Natrium fluoratum, sodium fluoride, Homeopathic preparation


subject: UMLS:C4733661

subject_name: Anti-CD33/CD3 Bispecific Antibody GEM 333

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4733661

object_name: acute myeloid leukemia


subject: UMLS:C4733661

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:164933665

subject_name: enlicitide

object_name: Hepatic impairment


subject: PUBCHEM.COMPOUND:164933665


subject: UNII:R7EZ772VG2

subject_name: ENLICITIDE


subject: UNII:R7EZ772VG2


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: age


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:145924

subject_name: Kaletra

object_name: HIV-1 infection


subject: UMLS:C0962969

subject_name: RAD 001

object_name: endometrial cancer


subject: UMLS:C0962969

object_name: uterine corpus cancer


subject: UMLS:C0962969

object_name: endometrial carcinoma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Plasma cell myeloma refractory


subject: CHEBI:79699

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:79699

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:79699

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:79699

object_name: ISS Stage II Plasma Cell Myeloma


subject: CHEBI:79699

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:79699

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:7459

subject_name: Naloxone

object_name: Post-Operative Pain


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Post-Traumatic Headache


subject: UMLS:C0885501

subject_name: Lac defloratum homeopathic preparation

object_name: Hypercholesterolemia


subject: UMLS:C0885501

object_name: cardiovascular disorder


subject: PR:000004318

subject_name: arrestin-C

object_name: prostate carcinoma


subject: PR:000004318

object_name: prostate cancer


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: cocaine abuse


subject: CHEBI:3387

object_name: substance-related disorder


subject: UMLS:C4723695

subject_name: penpulimab

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: uveal melanoma


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:6121

subject_name: Ketamine

object_name: obstructive sleep apnea syndrome


subject: GTOPDB:12989

subject_name: toripalimab

object_name: head and neck squamous cell carcinoma


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:35176

subject_name: Zinc sulfate

object_name: sickle cell disease


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: UMLS:C3641122


subject: GTOPDB:8323

subject_name: monalizumab

object_name: superficial urinary bladder carcinoma


subject: GTOPDB:8323


subject: UNII:3ZXZ2V0588


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C3896730


subject: GTOPDB:13791

subject_name: sacituzumab tirumotecan

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:3DV5TD1VL3

subject_name: SACITUZUMAB TIRUMOTECAN


subject: UMLS:C1449659

subject_name: 4-Aminopyridine Sustained Release

object_name: Spasticity


subject: UMLS:C1449659

object_name: spinal cord injury


subject: CHEBI:73611

subject_name: Met-Gly

object_name: voice disorders


subject: CHEBI:73611

object_name: Dysphonia


subject: CHEBI:73611

object_name: Hoarse voice


subject: CHEBI:73611

object_name: Spastic Dysphonia


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: invasive breast carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Irritable heart


subject: CHEBI:9584

subject_name: desiccated thyroid extract

object_name: Euthyroid (finding)


subject: CHEBI:9584

object_name: Neoplasm of uncertain or unknown behavior of thyroid gland


subject: CHEBI:9584

object_name: thyroid disease


subject: CHEBI:9584

object_name: reported prior thyroid disease (history)


subject: PUBCHEM.COMPOUND:23670461

subject_name: Thyradin


subject: PUBCHEM.COMPOUND:23670461


subject: PUBCHEM.COMPOUND:23670461


subject: PUBCHEM.COMPOUND:23670461


subject: CHEBI:143076

subject_name: N(pros)-methyl-L-histidine zwitterion

object_name: intestinal disorder


subject: CHEBI:133609

subject_name: 3-methylhistidine zwitterion


subject: UMLS:C0047600


subject: UNII:45T8YQ8DDW

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL4802167


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: leukemia


subject: CHEBI:231651

object_name: childhood leukemia


subject: CHEBI:231651

object_name: myeloid leukemia


subject: CHEBI:231651

object_name: acute disease


subject: CHEBI:231651

object_name: Myelodysplasia


subject: CHEBI:32599

object_name: cerebral palsy


subject: CHEBI:32599

object_name: periventricular leukomalacia


subject: CHEBI:32599

object_name: Periventricular Leukomalacia, AE


subject: CHEBI:32599

object_name: Intraventricular hemorrhage


subject: CHEBI:32599

object_name: placental abruption


subject: CHEBI:32599

object_name: pulmonary edema


subject: CHEBI:32599

object_name: Pulmonary Edema, CTCAE


subject: CHEBI:3441

subject_name: Carvedilol

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: diabetic retinopathy


subject: UMLS:C3529192


subject: UNII:P76B05O5V6

subject_name: Relugolix

object_name: prostate neoplasm


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: temporal arteritis


subject: UNII:4F4X42SYQ6

object_name: polymyalgia rheumatica


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C4687482

subject_name: BRD4 Inhibitor PLX2853

object_name: Advanced Uveal Melanoma


subject: UMLS:C4687482

object_name: Unresectable Uveal Melanoma


subject: UMLS:C4687482

object_name: Metastatic Uveal Melanoma


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:231005

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:231005

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: UMLS:C3896871

object_name: Solid Neoplasm


subject: UNII:OJE5810C4F

subject_name: Taxoprexin

object_name: liver cancer


subject: UNII:OJE5810C4F

object_name: liver carcinoma


subject: UMLS:C1135143


subject: UMLS:C1135143


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: leukocyte adhesion deficiency 1


subject: UNII:12WJ62D047

subject_name: Verinurad

object_name: chronic kidney disease


subject: UNII:12WJ62D047

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: inflammatory bowel disease


subject: UNII:3M6325NY1R

object_name: irritable bowel syndrome


subject: UMLS:C3661066

object_name: Ascending aortic dissection


subject: UMLS:C3661066

object_name: Ascending tubular aorta aneurysm


subject: UMLS:C3661066

object_name: Ascending aorta abnormality


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: coronary artery disorder


subject: UNII:C8ADC441ME

object_name: Abnormal left ventricular function


subject: CHEBI:84500

subject_name: varenicline

object_name: cocaine dependence


subject: UMLS:C0140430

subject_name: RHO(D) antibody

object_name: hepatitis C


subject: UMLS:C0140430

object_name: thrombocytopenia


subject: UMLS:C0140430

object_name: HIV infection


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)

object_name: Abdominal pain


subject: UMLS:C2012940

object_name: Abdominal Pain, CTCAE


subject: UMLS:C2012940

object_name: chronic pain (diagnosis)


subject: UMLS:C2012940

object_name: Chronic pain


subject: UMLS:C2012940

object_name: chronic pancreatitis


subject: UMLS:C2012940

object_name: hereditary chronic pancreatitis


subject: CHEBI:66964

subject_name: Dronabinol


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964


subject: CHEBI:66964


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: developmental disability


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C4329313


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: PUBCHEM.COMPOUND:2269

object_name: euthyroid Graves orbitopathy


subject: PUBCHEM.COMPOUND:2269

object_name: endocrine exophthalmos


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UNII:E8R04MBQ04

object_name: plasma cell myeloma


subject: UMLS:C2830202


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: esophageal squamous cell carcinoma


subject: UNII:5S371K6132

object_name: poisoning


subject: CHEBI:7773

subject_name: Ondansetron

object_name: inflammatory bowel disease


subject: CHEBI:7773

object_name: eosinophilic gastroenteritis


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:7773

object_name: Hematochezia


subject: CHEBI:7773

object_name: Bloody diarrhea


subject: CHEBI:7773

object_name: Weight loss


subject: CHEBI:7773

object_name: Weight Loss, CTCAE


subject: CHEBI:7773

object_name: diarrhea


subject: CHEBI:7773

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:7773

object_name: Diarrhea, CTCAE


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: Hodgkin Disease


subject: PUBCHEM.COMPOUND:11654566

object_name: Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Childhood Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2109475

object_name: type 2 diabetes mellitus


subject: UMLS:C0379528

subject_name: gamma-Secretase

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C0379528

object_name: stage IV pancreatic cancer


subject: UMLS:C0379528

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C0379528

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C0379528

object_name: pancreatic adenocarcinoma


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49603

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:49603

object_name: male breast carcinoma


subject: CHEBI:49603

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:49603

object_name: CNS metastases


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: Chemotherapy induced neutropenia


subject: UMLS:C3852764

object_name: myelosuppression


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Extrahepatic Cholangiocarcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:61606

object_name: coronary microvascular disorder


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: CHEBI:230791

subject_name: tributyrylglycerol

object_name: Memory observations


subject: CHEBI:35020

subject_name: Tributyrin


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:95165

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: bipolar disorder


subject: CHEBI:64019

subject_name: Nebivolol

object_name: interstitial lung disease 1


subject: CHEBI:64019

object_name: interstitial lung disease 2


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: UMLS:C5417942

object_name: melanoma


subject: UMLS:C5417942

object_name: metastatic melanoma


subject: UMLS:C5417942

object_name: Recurrent Metastatic Melanoma


subject: UMLS:C5417942

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: UMLS:C5564937

subject_name: HDT-301 vaccine


subject: CHEMBL.COMPOUND:CHEMBL1743018

subject_name: FICLATUZUMAB

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UMLS:C2703138

subject_name: ficlatuzumab


subject: UNII:9G2MP84A8W

object_name: epilepsy


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: Liver Fibrosis


subject: UMLS:C2348288

object_name: hepatitis B


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: CHEBI:35176


subject: MESH:C515299

subject_name: amodiaquine, artesunate drug combination

object_name: Uncomplicated malaria


subject: MESH:C086083


subject: CHEBI:195280

subject_name: Artemether


subject: CHEBI:156095

subject_name: Lumefantrine


subject: CHEBI:73770

subject_name: Ala-Leu


subject: CHEBI:73838

subject_name: D-Ala-Leu


subject: CHEBI:30136

subject_name: Aluminium


subject: CHEBI:28984

subject_name: aluminium atom


subject: UNII:G04B77F772

subject_name: BATABULIN SODIUM

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C1523985

subject_name: Batabulin Sodium


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Pregnancy in Diabetics


subject: UMLS:C3714501

object_name: Diabetes mellitus arising in pregnancy, insulin-requiring


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:6801


subject: CHEBI:31355

subject_name: Carboplatin

object_name: High Risk Neuroblastoma


subject: UMLS:C0699319

subject_name: Cytoxan


subject: UMLS:C0699319

object_name: Childhood Neuroblastoma


subject: UMLS:C0699319

object_name: neuroblastoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:187893

subject_name: Baclofen

object_name: Cheyne-Stokes respiration


subject: PUBCHEM.COMPOUND:21873174

subject_name: Testosterone undecanoate

object_name: Delayed Puberty, CTCAE


subject: PUBCHEM.COMPOUND:21873174

object_name: Delayed puberty


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: UMLS:C1699394

subject_name: Hylenex

object_name: allergic contact dermatitis


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Lipohypertrophy


subject: CHEBI:167574

object_name: Lipohypertrophy, CTCAE


subject: CHEBI:167574

object_name: AIDS


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: substance-related disorder


subject: CHEBI:17045

object_name: opiate dependence


subject: UMLS:C1831598

object_name: inborn mitochondrial metabolism disorder


subject: UMLS:C1831598

object_name: mitochondrial disease


subject: UniProtKB:P19726

subject_name: CAPSA_BPT7 Major capsid protein (sprot)

object_name: cancer


subject: UniProtKB:P19726

object_name: neoplasm


subject: UniProtKB:P19726

object_name: lung cancer


subject: UniProtKB:P19726

object_name: colon carcinoma


subject: UniProtKB:P19726

object_name: colorectal cancer


subject: UniProtKB:P19726

object_name: colon cancer


subject: UniProtKB:P19726

object_name: Childhood Breast Carcinoma


subject: UniProtKB:P19726

object_name: breast carcinoma


subject: UniProtKB:P19726

object_name: breast cancer


subject: UniProtKB:P19726

object_name: glioma


subject: UniProtKB:P19726

object_name: malignant glioma


subject: UniProtKB:P19726

object_name: malignant soft tissue neoplasm


subject: UniProtKB:P19726

object_name: sarcoma


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: PUBCHEM.COMPOUND:166625371


subject: CHEBI:6121

subject_name: Ketamine

object_name: persian gulf syndrome


subject: UNII:FOF5155FMZ

object_name: Myelodysplasia


subject: UNII:FOF5155FMZ

object_name: Miller-Dieker lissencephaly syndrome


subject: UNII:FOF5155FMZ

object_name: myoclonic dystonia 11


subject: UNII:FOF5155FMZ

object_name: adult acute myeloid leukemia


subject: UMLS:C5446299

subject_name: Eganelisib


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: UMLS:C5690696

subject_name: MitoQ

object_name: Ulcerative Colitis Flare


subject: MESH:D059002

subject_name: Androgen Receptor Antagonists

object_name: prostate carcinoma


subject: MESH:D059002

object_name: prostate cancer


subject: UMLS:C2936804


subject: UMLS:C2936804


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: Depressed mood


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Cancer patients and suicide and depression


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Depressed - symptom


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Depression, CTCAE


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:2639

subject_name: Amiloride

object_name: bipolar disorder


subject: CHEBI:76842

object_name: multiple sclerosis


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL3833369

object_name: Insulin resistance


subject: CHEBI:231678

subject_name: Evofosfamide

object_name: High grade glioma


subject: CHEBI:231678

object_name: malignant glioma


subject: CHEBI:73604

subject_name: Lys-Gly


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: endometrial cancer


subject: UNII:KXG2PJ551I

object_name: uterine corpus cancer


subject: UNII:KXG2PJ551I

object_name: endometrial carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896750

object_name: interstitial lung disease 1


subject: UMLS:C3896750

object_name: interstitial lung disease 2


subject: UMLS:C0592792

subject_name: Campral

object_name: alcohol abuse


subject: UMLS:C0592792

object_name: alcohol dependence


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: aspirin resistance


subject: UMLS:C3884615

object_name: Crohn disease


subject: CHEBI:9150

subject_name: Simvastatin

object_name: type 1 diabetes mellitus 1


subject: CHEBI:49040

subject_name: Ezetimibe


subject: CHEBI:49040

object_name: type 1 diabetes mellitus


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:31355

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: CHEBI:31355

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:31355

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:31355

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:31355

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231614

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:231614

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: CHEBI:231614

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231614

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231614

object_name: Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:231614

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:231614

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:231614

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:231614

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:231614

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2346820

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: UMLS:C2346820

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: UMLS:C2346820

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2346820

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2346820

object_name: Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UMLS:C2346820

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: UMLS:C2346820

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: UMLS:C2346820

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: UMLS:C2346820

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C2346820

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:45863

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: CHEBI:45863

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:45863

object_name: Oropharyngeal squamous cell carcinoma stage II


subject: CHEBI:45863

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: CHEBI:45863

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:45863

object_name: Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:16796

subject_name: Melatonin

object_name: Osteopenia


subject: UNII:426P9HSR8I

subject_name: PROGERININ

object_name: Werner syndrome


subject: DRUGBANK:DB17634

subject_name: Progerinin


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: liver carcinoma


subject: UMLS:C5556786

subject_name: TGF-beta Receptor 1 Inhibitor GFH018

object_name: Advanced Malignant Solid Neoplasm


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: bladder tumor


subject: MESH:C520255

object_name: urinary bladder carcinoma


subject: MESH:C520255

object_name: urinary bladder cancer


subject: MESH:C520255

object_name: childhood bladder carcinoma


subject: UNII:D2A6T4UH9C

subject_name: Centanafadine

object_name: binge eating


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: endometrial carcinoma


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: UMLS:C5238480

object_name: Prostate cancer recurrent


subject: UMLS:C4727626

subject_name: MVA-BN-brachyury-TRICOM vaccine

object_name: Safety Issues


subject: UMLS:C4725009

subject_name: FPV-Brachyury-TRICOM Vaccine


subject: UMLS:C0013162

subject_name: Drug Combinations

object_name: ischemia


subject: UMLS:C0013162

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: UMLS:C0013162

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: UMLS:C0013162

object_name: Poisoning by anticoagulant


subject: CHEBI:73832

subject_name: Asp-Val

object_name: superficial urinary bladder carcinoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Stage II Lung Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IB Lung Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage III Lung Cancer AJCC v8


subject: UNII:6QVL057INT

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB


subject: UNII:OX5LRQ5H6K


subject: UNII:OX5LRQ5H6K


subject: UNII:OX5LRQ5H6K

object_name: non-small cell lung carcinoma


subject: UNII:OX5LRQ5H6K


subject: UNII:OX5LRQ5H6K


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: UMLS:C4329332


subject: CHEBI:8364

subject_name: Prazosin

object_name: Post-Traumatic Headache


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: RENAL FAILURE CHRONIC REQUIRING HEMODIALYSIS


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Advanced cancer


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:91327

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:91327

object_name: Recurrent ovarian cancer


subject: CHEBI:59902

subject_name: ENTECAVIR

object_name: Decompensated cirrhosis of liver


subject: CHEBI:473990

subject_name: Entecavir


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Osteopenia


subject: UMLS:C1527137

object_name: osteoporosis


subject: UMLS:C1527137

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C1527137

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C1527137

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: PUBCHEM.COMPOUND:181658

subject_name: Strontium citrate


subject: PUBCHEM.COMPOUND:181658


subject: PUBCHEM.COMPOUND:181658


subject: PUBCHEM.COMPOUND:181658


subject: PUBCHEM.COMPOUND:181658


subject: UMLS:C2718459

subject_name: STRONTIUM (AS CITRATE)


subject: UMLS:C2718459


subject: UMLS:C2718459


subject: UMLS:C2718459


subject: UMLS:C2718459


subject: CHEBI:73558

subject_name: D3 vitamins


subject: CHEBI:73558


subject: CHEBI:73558


subject: CHEBI:73558


subject: CHEBI:73558


subject: CHEBI:173696

subject_name: KINURENAMINE


subject: CHEBI:173696


subject: CHEBI:173696


subject: CHEBI:173696


subject: CHEBI:173696


subject: UMLS:C3889727

subject_name: Viral Interleukin-6 Homolog


subject: UMLS:C3889727


subject: UMLS:C3889727


subject: UMLS:C3889727


subject: UMLS:C3889727


subject: PR:000009308

subject_name: kinesin-like protein KIF2A


subject: PR:000009308


subject: PR:000009308


subject: PR:000009308


subject: PR:000009308


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: endometriosis


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: respiratory system disorder


subject: UNII:5S371K6132

object_name: lung disorder


subject: UNII:5S371K6132

object_name: neoplasm of thorax


subject: UMLS:C5666990

subject_name: HIF2-alpha Inhibitor NKT2152

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5666990

object_name: clear cell renal carcinoma


subject: UMLS:C5666990

object_name: carcinoma


subject: UMLS:C5666990

object_name: Advanced renal cell carcinoma


subject: UMLS:C5666990

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C5666990

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C5666990

object_name: renal cell carcinoma


subject: UMLS:C5666990

object_name: Renal cell carcinoma recurrent


subject: UMLS:C5666990

object_name: Refractory Renal Cell Carcinoma


subject: UMLS:C5666990

object_name: renal carcinoma


subject: UMLS:C5666990

object_name: kidney cancer


subject: UMLS:C5666990

object_name: esophageal adenocarcinoma


subject: UMLS:C5666990

object_name: lung adenocarcinoma


subject: UMLS:C5666990

object_name: cervical adenocarcinoma


subject: UMLS:C5666990

object_name: adenocarcinoma


subject: UMLS:C5666990

object_name: bile duct adenocarcinoma


subject: UMLS:C5666990

object_name: gastric adenocarcinoma


subject: UMLS:C5666990

object_name: kidney neoplasm


subject: UMLS:C5666990

object_name: Epithelioma


subject: UMLS:C5666990

object_name: Neoplasm by histology


subject: UMLS:C5666990

object_name: Neoplasm of the genitourinary tract


subject: UMLS:C5666990

object_name: benign urinary system neoplasm


subject: UMLS:C5666990

object_name: urinary system neoplasm


subject: UMLS:C5666990

object_name: cancer


subject: UMLS:C5666990

object_name: urinary system disorder


subject: UMLS:C5666990

object_name: kidney disorder


subject: UMLS:C5666990

object_name: neoplasm


subject: CHEBI:85993

subject_name: Palbociclib

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:85993

object_name: clear cell renal carcinoma


subject: CHEBI:85993

object_name: carcinoma


subject: CHEBI:85993

object_name: Advanced renal cell carcinoma


subject: CHEBI:85993

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:85993

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:85993

object_name: renal cell carcinoma


subject: CHEBI:85993

object_name: Renal cell carcinoma recurrent


subject: CHEBI:85993

object_name: Refractory Renal Cell Carcinoma


subject: CHEBI:85993

object_name: renal carcinoma


subject: CHEBI:85993

object_name: kidney cancer


subject: CHEBI:85993

object_name: esophageal adenocarcinoma


subject: CHEBI:85993

object_name: lung adenocarcinoma


subject: CHEBI:85993

object_name: cervical adenocarcinoma


subject: CHEBI:85993

object_name: adenocarcinoma


subject: CHEBI:85993

object_name: bile duct adenocarcinoma


subject: CHEBI:85993

object_name: gastric adenocarcinoma


subject: CHEBI:85993

object_name: kidney neoplasm


subject: CHEBI:85993

object_name: Epithelioma


subject: CHEBI:85993

object_name: Neoplasm by histology


subject: CHEBI:85993

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:85993

object_name: benign urinary system neoplasm


subject: CHEBI:85993

object_name: urinary system neoplasm


subject: CHEBI:85993

object_name: cancer


subject: CHEBI:85993

object_name: urinary system disorder


subject: CHEBI:85993

object_name: kidney disorder


subject: CHEBI:85993

object_name: neoplasm


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Cirrhosis


subject: CHEBI:8228

object_name: liver cirrhosis


subject: CHEBI:8228

object_name: portal hypertension


subject: CHEBI:8228

object_name: Portal Hypertension, CTCAE


subject: CHEBI:8228

object_name: Ascites


subject: CHEBI:8228

object_name: Ascites, CTCAE


subject: CHEBI:84040

object_name: eye disorder


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: UMLS:C1101322

subject_name: trans-Resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Parkinson disease


subject: UNII:UC95NQ339C

object_name: Parkinsonism


subject: UNII:UC95NQ339C

object_name: seborrheic dermatitis


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: PUBCHEM.COMPOUND:4715169

object_name: long COVID-19


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:64356


subject: UNII:X7ZL2B4O1U

object_name: Post-Operative Pain


subject: PUBCHEM.COMPOUND:53312127

object_name: Microvascular coronary artery disease


subject: GTOPDB:9161

subject_name: ulocuplumab

object_name: Waldenstrom macroglobulinemia


subject: CHEMBL.COMPOUND:CHEMBL3039543

subject_name: ULOCUPLUMAB


subject: UMLS:C2987400


subject: UMLS:C5446557

subject_name: Anti-CCR7 Antibody-drug Conjugate JBH492

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5446557

object_name: non-Hodgkin lymphoma


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Impacted third molar tooth


subject: CHEBI:5855

object_name: Complication of other surgical procedures


subject: CHEBI:17026

subject_name: Progesterone

object_name: cocaine abuse


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:8452

subject_name: Proflavine

object_name: Anal intraepithelial neoplasia


subject: CHEBI:8452

object_name: polyp of colon


subject: CHEBI:8452

object_name: colon dysplasia


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: postpartum hemorrhage


subject: UMLS:C5203530

object_name: Post-partum hemorrhage


subject: UNII:46D4HS9ODA

subject_name: Samuraciclib

object_name: Childhood Breast Carcinoma


subject: UNII:46D4HS9ODA

object_name: breast carcinoma


subject: UNII:46D4HS9ODA

object_name: breast cancer


subject: DRUGBANK:DB19006

subject_name: Vepdegestrant


subject: DRUGBANK:DB19006


subject: DRUGBANK:DB19006


subject: UNII:9TG5O4V25H

object_name: plasma cell myeloma


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Stress (Physiology)


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: acute respiratory distress syndrome


subject: UMLS:C5400018

object_name: adult acute respiratory distress syndrome


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UNII:438HCF2X0M


subject: CHEBI:177504

subject_name: Butylphthalide

object_name: focal epilepsy


subject: CHEBI:177504

object_name: Cognitive impairment


subject: UMLS:C4051515

subject_name: PCSK9 Inhibitor [EPC]

object_name: coronary artery disorder


subject: UMLS:C4051515

object_name: coronary atherosclerosis


subject: UMLS:C4521460

subject_name: Substance with proprotein convertase subtilisin/kexin type 9 inhibitor mechanism of action


subject: UMLS:C4521460


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Ventricular arrhythmia


subject: CHEBI:4466

object_name: Recurrent ventricular tachycardia


subject: CHEBI:4466

object_name: ventricular fibrillation


subject: CHEBI:4466

object_name: Ventricular Fibrillation by ECG Finding


subject: CHEBI:4466

object_name: continuous electrocardiogram ventricular fibrillation


subject: CHEBI:4466

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: CHEBI:4466

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: CHEBI:4466

object_name: ventricular tachycardia


subject: CHEBI:4466

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: CHEBI:4466

object_name: continuous electrocardiogram ventricular tachycardia


subject: CHEBI:4466

object_name: Ventricular Tachycardia by ECG Finding


subject: CHEBI:4466

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: carcinoma of biliary tract


subject: CHEBI:140628

subject_name: Secnidazole

object_name: giardiasis


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:4466

object_name: Pathologic Processes


subject: CHEBI:4466

object_name: cognitive disorder


subject: CHEBI:4466

object_name: mental disorder


subject: CHEBI:4466

object_name: psychiatric disorder


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:78870

subject_name: sodium nitrite

object_name: type 2 diabetes mellitus


subject: CHEBI:78870

object_name: Diabetes


subject: CHEBI:78870

object_name: diabetes mellitus


subject: UNII:ZA45457L1K

subject_name: Evobrutinib

object_name: kidney failure


subject: CHEBI:6931

subject_name: Midazolam

object_name: Cerebral Hypoxia-Ischemia


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: pregnancy disorder


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:84040

object_name: Prediabetes


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:4672

subject_name: Docetaxel

object_name: leukemia


subject: CHEBI:4672

object_name: childhood leukemia


subject: CHEBI:36219

subject_name: lactose

object_name: bacterial vaginosis


subject: CHEBI:36218

subject_name: beta-lactose


subject: UMLS:C1260222

subject_name: Saccharum lactis, Homeopathic preparation


subject: UMLS:C1696723

subject_name: lactose - non-drug agent


subject: CHEBI:60791

subject_name: Xylocard

object_name: migraine


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: amenorrhea


subject: UNII:TL60C27RLH

object_name: Amenorrhea, CTCAE


subject: UMLS:C0909862

subject_name: recombinant methionyl human leptin


subject: UMLS:C0909862


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: postmenopausal osteoporosis


subject: CHEBI:231356

subject_name: Varlitinib

object_name: biliary tract cancer


subject: CHEBI:231356

object_name: liver carcinoma


subject: CHEBI:2704

subject_name: Anastrozole

object_name: hypogonadotropic hypogonadism


subject: CHEBI:2704

object_name: Klinefelter syndrome


subject: CHEBI:2704

object_name: Kallmann syndrome


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: RXCUI:8375


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:6801

subject_name: Metformin

object_name: Thyroid nodule


subject: CHEBI:6801

object_name: nodule of thyroid by palpation


subject: CHEBI:167574

subject_name: Semaglutide

object_name: pseudotumor cerebri


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: fat; intolerance, pancreas


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: melanoma


subject: UNII:4EQZ6YO2HI

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:4EQZ6YO2HI

object_name: metastatic melanoma


subject: UNII:4EQZ6YO2HI

object_name: skin melanoma


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: cervical polyp


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: bipolar disorder


subject: CHEBI:71954

subject_name: Buparlisib

object_name: High risk of recurrence, prostate cancer (PRCA)


subject: CHEBI:60799

subject_name: Esketamine

object_name: Control of hip fracture risk


subject: CHEBI:60799

object_name: hip fracture


subject: UMLS:C0678021

subject_name: Ad5CMV-p53 gene

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: UMLS:C0677806

subject_name: adenovirus p53 gene therapy agent


subject: UMLS:C2346820


subject: CHEBI:31348

subject_name: Capecitabine


subject: DRUGBANK:DB05597

object_name: peripheral vascular disease


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: UNII:4I67US2V8Q

object_name: endogenous depression


subject: UNII:4I67US2V8Q

object_name: major depressive disorder


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: CHEMBL.COMPOUND:CHEMBL3545406


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Childhood Favorable Prognosis Hodgkin Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: Stage I Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Stage II Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Childhood Mixed Cellularity Classic Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Childhood Nodular Sclerosis Classic Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:8382

subject_name: Prednisone


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: PUBCHEM.COMPOUND:9549299

subject_name: EGFR inhibitor

object_name: head and neck squamous cell carcinoma


subject: PUBCHEM.COMPOUND:9549299

object_name: Squamous cell carcinoma of head and neck metastatic


subject: PUBCHEM.COMPOUND:9549299

object_name: squamous cell carcinoma


subject: UMLS:C5574906

subject_name: Epidermal growth factor receptor inhibitor


subject: UMLS:C5574906


subject: UMLS:C5574906


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Hepatic impairment


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: lymphedema


subject: UNII:2S9ZZM9Q9V

object_name: Lymphedema, CTCAE


subject: CHEBI:48923

subject_name: erythromycin

object_name: bulimia nervosa


subject: CHEBI:48923

object_name: eating disorder


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:31355

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:5864


subject: CHEBI:5864

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:5864


subject: UMLS:C1258613

subject_name: oblimersen sodium


subject: UMLS:C1258613


subject: UMLS:C1258613


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UMLS:C0678023

subject_name: LMB-9 Immunotoxin

object_name: pancreatic neoplasm


subject: UMLS:C0678023

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0678023

object_name: malignant pancreatic neoplasm


subject: UMLS:C0678023

object_name: colorectal cancer


subject: UMLS:C0678023

object_name: colorectal carcinoma


subject: UMLS:C0678023

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0678023

object_name: carcinoma of esophagus


subject: UMLS:C0678023

object_name: esophageal cancer


subject: UMLS:C0678023

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C0678023

object_name: neoplasm of esophagus


subject: UMLS:C0678023

object_name: Stomach cancer


subject: UMLS:C0678023

object_name: gastric cancer


subject: UMLS:C0678023

object_name: bladder tumor


subject: UMLS:C0678023

object_name: urinary bladder carcinoma


subject: UMLS:C0678023

object_name: urinary bladder cancer


subject: UMLS:C0678023

object_name: childhood bladder carcinoma


subject: UMLS:C0678023

object_name: Childhood Breast Carcinoma


subject: UMLS:C0678023

object_name: breast carcinoma


subject: UMLS:C0678023

object_name: breast cancer


subject: UMLS:C0678023

object_name: lung cancer


subject: UMLS:C0678023

object_name: lung neoplasm


subject: UMLS:C0678023

object_name: lung carcinoma


subject: UMLS:C4744992

subject_name: Factor B Inhibitor LNP023

object_name: paroxysmal nocturnal hemoglobinuria


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: urgency urinary incontinence


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:25805

subject_name: oxygen atom

object_name: Hyperoxemia


subject: CHEBI:25805

object_name: Fraction of inspired oxygen


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: MESH:C581750

subject_name: hemospray

object_name: Upper gastrointestinal hemorrhage


subject: CHEBI:135905

subject_name: Terlipressin

object_name: liver failure


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: brain injury


subject: PUBCHEM.COMPOUND:92043599

object_name: Periventricular Leukomalacia, AE


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579

object_name: Intraventricular hemorrhage


subject: CHEBI:81579

object_name: periventricular leukomalacia


subject: CHEBI:81579


subject: DRUGBANK:DB18340

object_name: Krabbe disease


subject: CHEBI:31684

subject_name: Ibudilast

object_name: viral pneumonia


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Childhood Breast Carcinoma


subject: CHEBI:38545

object_name: breast carcinoma


subject: CHEBI:38545

object_name: breast cancer


subject: CHEBI:4974

subject_name: Famciclovir

object_name: Recurrent oral herpes


subject: MESH:D010919

subject_name: Placebos

object_name: cryopyrin-associated periodic syndrome


subject: CHEBI:5163

subject_name: fosinopril

object_name: Chronic uremia


subject: CHEBI:5163

object_name: proteinuria


subject: CHEBI:5163

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:5163

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:5163

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:167574

subject_name: Semaglutide

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: temporomandibular joint disorder


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UNII:B4S8ET206U

subject_name: Denintuzumab mafodotin

object_name: grade 3B follicular lymphoma


subject: UNII:B4S8ET206U

object_name: diffuse large B-cell lymphoma


subject: UNII:B4S8ET206U

object_name: B-cell neoplasm


subject: UNII:H5324S1M7H

subject_name: DENINTUZUMAB MAFODOTIN


subject: UNII:H5324S1M7H


subject: UNII:H5324S1M7H


subject: UMLS:C4477221

subject_name: depatuxizumab mafodotin


subject: UMLS:C4477221


subject: UMLS:C4477221


subject: UMLS:C3641944

subject_name: SGN CD19A


subject: UMLS:C3641944


subject: UMLS:C3641944


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:31186

object_name: obesity


subject: CHEBI:31186

object_name: Obesity, CTCAE


subject: CHEBI:45783

subject_name: Imatinib

object_name: Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C3896749

object_name: glioblastoma


subject: UMLS:C3896749

object_name: Brain Stem Glioblastoma


subject: UMLS:C3896749

object_name: glioma susceptibility 1


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Tinnitus


subject: CHEBI:42797

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:42797

object_name: Tinnitus, CTCAE 3.0


subject: CHEBI:45783

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:45783

object_name: chronic myelomonocytic leukemia


subject: CHEBI:45783

object_name: systemic mastocytosis


subject: CHEBI:45783

object_name: dermatofibrosarcoma protuberans


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: heart failure


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Peripheral T-cell lymphoma unspecified refractory


subject: CHEBI:231614

object_name: hepatosplenic T-cell lymphoma


subject: CHEBI:231614

object_name: NK-Cell Lymphoma, Unclassifiable


subject: CHEBI:231614

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: CHEBI:231614

object_name: Angioimmunoblastic T-cell lymphoma refractory


subject: CHEBI:231614

object_name: Intestinal T-cell lymphoma refractory


subject: CHEBI:231614

object_name: Angiocentric lymphoma refractory


subject: CHEBI:231614

object_name: Adult T-cell lymphoma/leukaemia refractory


subject: CHEBI:231614

object_name: Angioimmunoblastic T-cell lymphoma recurrent


subject: CHEBI:231614

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:231614

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:231614

object_name: Mycosis fungoides refractory


subject: CHEBI:231614

object_name: Intestinal T-cell lymphoma recurrent


subject: CHEBI:231614

object_name: Systemic Anaplastic Large Cell Lymphoma, ALK-Negative


subject: CHEBI:231614

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: CHEBI:231614

object_name: CD4+/CD56+ hematodermic neoplasm


subject: CHEBI:231614

object_name: Mycosis fungoides recurrent


subject: CHEBI:231614

object_name: human T-lymphotropic virus 1 infectious disease